trihexyphenidyl has been researched along with Catatonia in 6 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rao, NP | 1 |
| Loganathan, S | 1 |
| Prakash, O | 1 |
| Varghese, M | 1 |
| RASHKIS, HA | 1 |
| SMARR, ER | 1 |
| GERSON, IM | 1 |
| CHAT, E | 1 |
| TWIGGER, NA | 1 |
| Stoudemire, A | 1 |
| Luther, JS | 1 |
| Poignant, JC | 1 |
| Gressier, H | 1 |
| Malecot, E | 1 |
| Hitomi, M | 1 |
| Kumadaki, N | 1 |
| Furukawa, T | 1 |
| Ito, N | 1 |
| Sato, Y | 1 |
| Kumada, S | 1 |
6 other studies available for trihexyphenidyl and Catatonia
| Article | Year |
|---|---|
Use of electroconvulsive therapy for schizophrenia with comorbid Marfan syndrome.
Topics: Adult; Antipsychotic Agents; Catatonia; Electroconvulsive Therapy; Female; Humans; Marfan Syndrome; | 2009 |
Drug and milieu effects with chronic schizophrenics.
Topics: Amobarbital; Catatonia; Methylphenidate; Reserpine; Schizophrenia; Trihexyphenidyl | 1957 |
CLINICAL TRIAL OF A POTENTIATED DIKETOPIPERAZINE DERIVATIVE AS A PSYCHOPHARMACOLOGICAL AGENT FOR THE TREATMENT OF PSYCHOTIC PATIENTS.
Topics: Biomedical Research; Catatonia; Depression; Depressive Disorder; Diketopiperazines; Humans; Leukopen | 1964 |
Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Carbidopa; Catatonia; Diagnosis, Differential; F | 1984 |
Comparative effects of apomorphine, piribedil and other neurotropic agents on central analgesic-induced catatonia in the rat.
Topics: Amantadine; Analgesics, Opioid; Animals; Antiparkinson Agents; Apomorphine; Atropine; Benserazide; B | 1974 |
Pharmacological study of piroheptine, a new antiparkinson drug, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-ethyl-2-methylpyrrolidine. I. Effects on drug-induced tremor and catatonia, and on adrenergic actions.
Topics: Animals; Antiparkinson Agents; Atropine; Avoidance Learning; Catatonia; Cats; Conditioning, Psycholo | 1972 |